Publication | Closed Access

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

Radiation TherapyPhase I/ii StudyMedicineBronchial NeoplasmEtoposide AdministrationCancer TreatmentAltered ScheduleOncologyRadiation OncologyLung CancerRadiologyHealth Sciences